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Shortening of telomeres: Evidence for replicative senescence of
T cells derived from patients with Wegener’s granulomatosis
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Shortening of telomeres: Evidence for replicative senescence In previous studies by others [7], expression on T cells
of T cells derived from patients with Wegener’s granulomatosis. of CD25 was described, as well as loss of CD28 [10].
Background. Replicative senescence describes the fact that While up-regulation of CD25 and relative loss of CD28somatic cells undergo a finite and predictable number of cell
are associated with T-cell activation, the presence ofdivisions before entering an irreversible state of growth arrest.
these cells also in patients with inactive disease suggestedProgressive shortening of the telomeres, a consequence of cell
division, is a reliable indicator of replicative senescence. an alternative explanation. The CD25CD28 pheno-
Method. We analyzed telomere length of DNA derived from type was also described for T cells in the state of “replica-
T cells of patients suffering from Wegener’s granulomatosis tive senescence” occurring following recurrent stimula-by Sourthern blotting. Moreover, expression of CD28, another
tion and proliferation. As other somatic cells, clonallymarker for replicative senescence, was tested by cytofluoro-
expanded T cells stop proliferating after 30 to 40 popula-metry.
Results. In patients with disease for more than 5 years, short tion doublings [11, 12], in contrast to permanently grow-
telomeres were detected in addition to telomeres of normal ing T-cell leukemia lines. Replicative senescence is asso-
length, indicating replicative senescence of discrete T-cell ciated with reduction of telomere length. Telomeres areclones. Reduced expression of CD28 was noted, particularly
required for the chromosomal redistribution during cellon CD8-positive T cells, derived from patients with disease for
division and comprise several kilobases of tandem re-more than 5 years and short telomeres.
Conclusion. Our data provide evidence that a portion of peats, located at the chromosomal ends. Per population
T cells had undergone replicative senescence, which in turn doubling between 40 to 100 bp are lost, resulting in a
indicates clonal expansion of T cells as consequence of activa- progressive shortening of the telomeres and below ation.
critical length in growth arrest. Shortening of telomeres
explains to some extent why somatic cells undergo a
finite and predictable number of cell divisions [13–16].Wegener’s granulomatosis is defined as a primary nec-
Evidence for replicative senescence in vivo are found inrotizing vasculitis with granuloma formation, particularly
aged donors or in individuals with Down’s syndrome,in the respiratory tract. The etiology and pathogenesis
the latter frequently considered as a model for prematureof the disease is still under intense investigation. There
aging [16]. More recently, shortening of telomere lengthis, however, convincing evidence for immune and auto-
was reported in peripheral blood cells of patients suffer-immune phenomena especially for autoantibody forma-
ing from atherosclerosis [17].tion [reviewed in 1, 2]. While the relevance of the auto-
Another feature of senescent T cells, the loss of CD28,antibodies for the diagnosis of the disease is widely
the major costimulatory receptor involved in T-cell acti-accepted, there is still no agreement on their role in
vation [18–20], was seen in patients with human immuno-the pathogenesis of disease [1–3]. The same is true for
deficiency virus (HIV) infections [21, 22] or with rheuma-monocytes, neutrophils or T lymphocytes, although acti-
toid arthritis [23] and taken as evidence for replicativevation of these cells in relation to disease activity has
senescence as consequence of the disease. Since, how-been reported [4–9].
ever, CD28 is also down-regulated upon T-cell stimula-
tion via the T-cell receptor [24], lack of CD28 is not an
Key words: vasculitis, telomere length, CD28, T lymphocytes. unequivocal marker for replicative senescence.
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shortened telomeres as well as for lack of CD28 in a Determination of telomere length
portion of T cells, particularly in patients with long-term After isolation of genomic DNA, 3 g DNA was di-
disease. The data are consistent with the presence of gested with the restrictions enzymes RSA I (Roche,
senescent T cells and indicative of oligoclonal T-cell acti- Mannheim, Germany) and HindI (Roche) for 18 hours
vation. at 37C. The digested DNA was heated for 5 minutes at
56C and resolved by electrophoresis in a 0.6% agarose-
gel in 1  tris-acetic acid (TAE) at 30 V for 22 hours.METHODS
The gel was dried for 30 minutes at room temperature,Patients
45 minutes at 60C, and finally again for 30 minutes at
After approval by the Ethikkommission (Ethics Com- room temperature. Then the gel was denatured by rins-
mittee) of the University of Heidelberg Hospital and ing for 45 minutes in 0.5 mol/L NaOH, 0.15 mol/L NaCl,
after having obtained informed consent, patients with neutralized for 30 minutes in 0.5 mol/L Tris, 0.15 mol/L
Wegener’s granulomatosis attending the renal unit of NaCl, and finally washed in distilled water for 30 minutes.
the Heidelberg University Hospital were included in a Prehybridization was performed with buffer [5  stan-
prospective study. Wegener’s granulomatosis was diag- dard sodium citrate (SSC), 5  Denhards, 0.15 mol/L
nosed according to the definition of the Chapel Hill con- NaH2PO4, 1% sodium dodecyl sulfate (SDS)] for 18
ference [25] and to the American College of Rheumatol- hours at 40C.
ogy (ACR) criteria [26]. The patients differed with Telomere length was determined by a 5mer telomere
regard to severity and duration of the disease and thera- probe (CCCTAA, ARK Scientific, Sigma, Germany) us-
peutic regimen as well. At the time tested, none of the ing 100 pmol/L of the probe, the 5 labeling kit (Roche)
patients had active disease. There were essentially three strictly used 32P gamma adenosine triphosphate (ATP)
groups of patients: (1) patients with disease for longer (125 Ci; Pharmacia Amersham, Freiburg, Germany).
than 5 years (N 31); (2) patients with disease for longer After washing the gel twice in 1  SSC/0.1% SDS, it
than 5 years but with only one episode of active disease was exposed on a BioMax-film (Kodak, Rochester, NY,
(“one-shot”) (N  13); and (3) patients with disease for USA) for 1 to 4 hours until a clear signal was visible.
5 years or less (N  11). The age of patients ranged
For imaging a FLA 2000 (Fuji Film, Tokyo, Japan) was
from 24 to 77 years. For comparison, patients (N  8)
used. The telomere length was estimated by comparing
with nephritic diseases of causes other than Wegener’s
the size of the signal to the molecular weight markersgranulomatosis, and nonimmunologic genesis were in-
III and IV (Boehringer Mannheim) as described in [27].cluded (Table 1).
Determination of telomerase activityDonors
The TRAPeze telomerase detection kit was usedThirty-five age-matched healthy donors were included
(Oncor, Gaithersburg, MD, USA). T cells were washedin the study in addition to the specified donors.
twice with phosphate-buffered saline (PBS). After freez-
ing the pellet, it was resuspended in 3-[(3-cholamido-Isolation of T cells and B cells
propyl)dimethylammonio]-1-propanesulfonate (CHAPS)From peripheral, heparinized blood of healthy donors
lysing buffer according to the protocol. The sample wasor of patients with Wegener’s granulomatosis mononu-
resolved by a 4% to 17% gradient polyacrylamide gelclear cells (MNC) were separated by centrifugation on
for 11⁄2 hours at 400 V and then dried. The bands werePolymorphPrep(Nycomed, Oslo, Norway) for 30 min-
visualized after incubation for 30 minutes at room tem-utes at 1700 rpm. The T-cell fraction was further purified
perature in SYBRR Green (Molecular Probes, Leiden,by adsorption to CD3 beads by magnetic cell separation
The Netherlands) by FLA 2000 (Fuji Film).by Automags (MylteniBiotech, Bergisch-Gladbach, Ger-
many) using the devices supplied by MiltenyBiotech and
Determination of surface-associated CD28strictly following the instructions of the manufacturer.
on T lymphocytesB cells were enriched by using CD20 beads. Purity of
CD28 on T lymphocytes was detected by double-label-cell preparation was judged by cytofluorometry.
ing with fluorescein isothiocyanate (FITC)-conjugated
DNA extraction antibody to CD3 as specific marker for T cells and phy-
coerythrin (PE)-conjugated antibody to CD28 (both Im-Total DNA was isolated from 1 106 T cells or B cells
munotech, Marseille, France). To avoid changes in sur-using DNAeasy Tissue Kit (Quiagen, Hilden, Germany),
face expression due to handling procedures, antibodystrictly following the instructions of the manufacturer.
labeling was performed in whole blood within 2 hoursDNA was concentrated and purified by ethanol elution,
after withdrawal. To 100 L whole blood 10 L (finalconcentration was measured spectrophotometrically
(Eppendorf, Hamburg, Germany). concentration 10 g/mL) of the respective monoclonal
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Table 1. Telomere length, CD28 expression, and course of disease of patients with Wegener’s granulomatosis and patients with renal disease
of nonimmune origin
Duration CD28
Age of disease Telomere % positive
Patient years years Characterization of disease length T cells
P1 75 1 Multiple organ involvement (ears, joints, kidney); in remission Normal 60
P2 61 12 Multiple organ involvement (lung, kidney, eyes, ears, neurologic symptoms); progressive
kidney failure; multiple relapses; last relapse 6 months ago Short 71
P3 62 6 Predominantly localized eye and nose involvement; no relapses; in remission for 4 years Normal 86
P4 53 11 Multiple organ involvement (eyes, nose, lung, kidney); in complete remission for 9 years Normal 94
P5 77 9 Eye and ear involvement and multiple relapses; for 2 years also with renal and pulmonal
manifestations and increase of ANCA-titer; in complete remission for 2 years Normal 56
P6 65 9 Multiple organ involvement (nose, eyes, kidney) with progressive loss of renal function;
in remission for 6 months Short 68
P7 24 9 Multiple organ involvement (nose, ears, lung, skin); multiple relapses; in remission for
6 months Short 54
P8 62 5 Multiple organ involvement (nose, joints, kidney, skin): 2 relapses, in remission for
8 months Short 33
P9 57 5 Multiple organ involvement; in remission for 4 years Short 64
P10 60 1 Multiple organ involvement (nose, lung, joints, kidney) Normal 74
P11 34 10 Multiple organ involvement (nose, eyes, ears, kidney); in remission for 3 years Short 74
P12 59 7 In complete remission for 5 years Normal 85.5
P13 68 9 In complete remission for 7 years Normal 100
P14 68 15 Multiple organ involvement; muliple relapses; in remission for 2 years Short 80
P15 47 7 Multiple organ involvement; 2 relapses; progressive kidney failure Short 50
P16 55 3 Multiple organ involvement; rapidly progressing disease; multiple relapses Short 55
P17 72 6 Multiple organ involvement; in remission for 1 year Short 89.5
P18 51 5 Multiple organ involvement; in remission for 1 year Short 82
P19 53 6 Multiple organ involvement; 2 relapses; in remission for 2 years Short 91
P20 75 10 Multiple organ involvement; multiple relapses; in remission for 2 years Short 55
P21 53 6 Multiple organ involvement; multiple relapses; end-stage kidney failure Short 75
P22 59 7 Multiple organ involvement; 2 relapses; in remission for 2 years Short 75
Patients with renal disease of non-immune origin
C1 66 5 Analgesic nephropathy with chronic renal failure Normal 86.7
C2 70 5 Analgesic nephropathy with chronic renal failure Normal 94.9
C3 73 5 Polycystic kidney disease Normal 78.1
C4 60 5 Liver cirrhosis; asymptomatic postinfectious glomerulonephritis Normal 87.5
C5 33 	5 Acute interstitial nephritis Normal 98.8
C6 83 5 Benign nephrosclerosis Normal 88
C7 63 5 Polycystic kidney disease Normal 82.4
C8 61 	5 Relapsing interstitial nephritis Normal 94.5
antibodies (mAbs) were added and incubated for 30 box containing 50% of the values. The highest, lowest,
and the median values are depicted. Differences betweenminutes at room temperature. Red blood cells were lysed
by 2 mL fluorescence activated cell sorter (FACS) lysing the patients and the healthy donors were calculated by
t test for two independent populations. Coincidence be-solution, washed three times in FACS buffer and resus-
pended in 1% paraformaldehyde. For comparison iso- tween CD28 surface expression, telomere length and
disease was tested by the chi-square test.type-matched mouse immunoglobulin G (IgGs) (Sero-
tec) were used in comparable protein concentrations.
T-cell linesFor cytofluorometry of the T-cell clone fri-t, 1 106 cells
were suspended in PBS containing 1% bovine serum T-cell lines with specificity for Tetanus Toxin (TT, fri-t)
were established from a healthy, recently vaccinated do-albumin (BSA) and 0.1% Na-azide and incubated with
100 L of the diluted antibody for 30 minutes at room nor as described in Radsak et al [28]. Jurkat-cells (clone
K14) were used as a permanently growing cell line, pro-temperature. After washing three times in FACS buffer
cells were finally suspended in PBS containing 1% para- vided by Prof. Dr. B. Schraven (Magdeburg, Germany).
formaldehyde.
RESULTSStatistical analysis
Determination of telomere length in T cells ofCells were analyzed by FACS Calibur and CellQuest
patients with Wegener’s granulomatosissoftware (Becton Dickinson, Heidelberg, Germany). Re-
sults are expressed as the percentage CD28-positive T Telomere length was assessed by Southern blotting of
DNA isolated from peripheral T cells of patients withcells in the respective gate or quadrant. The results for
CD28 expression are presented as box blots, with the Wegener’s granulomatosis (N  22) and of healthy do-
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Fig. 1. Visualization of telomeres from T cells of patients with Wegener’s granulomatosis and healthy donors by Southern blot hybridization. On
the very left, the T cells of donor, fri, and the clonally expanded T cells, fri-t, are shown, then the T cells from patients P1 to P22, of patients with
renal diseases of nonimmune origin (C1 to C8) and of the donors D1 to D10. The arrow marks the location and the black dot the lanes where
short telomeres were found. Note: Samples of patient 1 were run as duplicates.
nors as well (N  10). Since telomere length decreases lapses. In only one patient with disease known for less
than 5 years were short telomeres seen. That patientswith age, care was taken to include age-matched donors.
As internal control, DNA isolated from peripheral (P16) had severe disease for an extended period of time.
In patients with disease for less than 5 years (P1 andT cells of one donor (fri) was used and, in parallel, DNA
of T cells of the same donor, clonally expanded with P10), or in patients with single episodes or localized
lesions (P3, P4, P12, and P13) no short telomeres weretetanus toxoid (fri-t) for 4 to 6 months. The T cells fri
had telomeres between 6.8 and 7.7 kb, corresponding to detected (data summarized in Table 1). The association
of short telomeres with long-term disease, on one hand,the expected length for normal donors of 6.5 to 9.5 bp,
whereas fri-t had considerably shorter telomeres (3.7 to and of telomeres of normal length with short-term dis-
ease, on the other hand, was more than accidental as5.2 kb) (Fig. 1). This finding is consistent with a progres-
sive shortening of telomeres with the number of cell calculated by chi-square test (13.7; P 	 0.001). Of nine
patients, telomere length also of B cells was tested indivisions occurring during clonal expansion and with the
observation, that fri-t stopped dividing after 30 to 35 cell addition to T cells. No short telomeres were found, de-
spite presence of short telomeres in T cells (data notdoublings.
In permanently growing cell lines, telomere length is shown).
For comparison, telomere length of T cells derivedmaintained by telomerase, a ribonucleoprotein that adds
nucleotides at the 3 end of existing telomeres. Jurkat from eight patients suffering from various forms of end-
stage renal disease (ESRD), but without history of auto-cells (clone K14) had telomerase activity, which is in
line with its growth characteristics and normal telomere immune disease or chronic inflammatory disease were
included (C1 to C8; summarized in Table 1). Short telo-length; in contrast, peripheral T cells did not express
telomerase activity (Fig. 2) nor did the clonally expanded meres were not detectable in any of the patients (Fig. 1).
Of the healthy donors (N  10) two had short telo-fri-t. As expected, no telomerase activity was found in
T cells of Wegener’s glanulmatosis patients (data not meres, and they were 80 and 97 years old, respectively
(D1, D2), but none of the donors in the age range ofshown).
When assessing telomere length of T cells derived the Wegener’s disease patients. The overall telomere
length calculated for healthy donors (9.5 
 1.2 kb) wasfrom patients with Wegener’s granulomatosis in 15 of
22 patients, two main areas of hybridization were found. not different from that seen for the patients (8.9
 2.9 kb).
One corresponded to telomeres of normal length and
Expression of CD28 on T cells of patients withone corresponded to the short telomeres of the T-cell
Wegener’s diseaseclone fri-t (Fig. 1). The 14 of 15 patients presenting with
the short telomeres had progressive disease for at least Another finding associated with replicative senescence
of T cells is the reduced surface expression of CD285 years, multiple organ involvement, and multiple re-
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Fig. 2. Assessment of telomerase activity in
T lymphocytes. The addition of telomeric re-
peats to a oligonucleotide substrate was mea-
sured with lysates of the clone, fri-t, of Jurkat
cells (K14), or of cells of donors fri. On the
right panel, the inherent controls of the TRA-
Peze-kit are shown. Abbreviations are: pos,
telomerase positive cells; TSR8, control tem-
plate. The arrows indicate the telomerase
products, which are not seen with peripheral
T cells or clonally expanded T cells.  marks
the freshly prepared lysates; the heat-inacti-
vated lysates.
[18, 19]. Again, these data were first verified using periph- number of cell divisions. Replicative senescence also ap-
eral T cells of the donor fri and the clonally expanded plies to T cells. Clonally expanded T cells stop growing
T-cell fri-t. The peripheral T cells expressed normal lev- after 30 to 40 cell cycles. As reported earlier by others
els of CD28 (90% 
 4%, measured at three different and confirmed in the present study using an antigen-
occasions). After approximately 30 population doublings specific T-cell clone, replicative senescence coincides
of fri-t only, 
 30% of T cells were still positive for with shortening of telomeres and loss of CD28 [16, 18, 19].
CD28 (Fig. 3A). To look for evidence of replicative senescence of
In healthy donors with about the same age distribution
T cells derived from patients with Wegener’s disease,as the patients with Wegener’s disease or in patients with
both, telomere length and loss of CD28 were determined.renal disease of nonimmune origin, CD28 expression
By Southern blotting in some patients two areas of hy-ranged from 75% to 97% (mean, 85.9%
 6.4%; median,
bridization were seen, one with telomeres of normal85%; N  30; and 89.1% 
 6.5%; median, 88%, respec-
length as expected, and another one, corresponding totively). A presumably age-related decrease was seen only
the telomeres, the clonally expanded T cells. The mostin individuals older than 80 years (Fig. 3B). The expres-
sion of CD28 on T cells of patients with Wegener’s dis- reasonable explanation is that the short telomeres were
ease was heterogeneous and ranged from 32% to 96% derived from discrete T-cell clones, which, due to re-
positive cells (mean, 77.2%
 17.3%; median, 84%, N peated activation, had undergone replicative senescence,
44). When only patients with disease for 5 years or longer while the majority of T cells had not been activated,
were considered (N  22), and patients with single epi- and, therefore, had not divided and consequently had
sodes of the disease were excluded (N  11), CD28 preserved their telomeres. This explanation is supported
expression was significantly lower when compared to
by the fact that the short telomeres are found in patientshealthy donors to patients with disease for less than 5
with long-lasting disease and multiple relapses, but notyears (N  11) or to patients with single episodes of the
in patients with single episodes or short course of disease.disease (N  11) (largest P  0.03) (data summarized
With regard to the pathogenesis of Wegener’s disease,in Fig. 4A). Loss of CD28 was mainly within the CD8-
these data can be taken as evidence for oligoclonal, re-positive T-cell population, and only in few patients also
current activation of T cells and for restimulation of thewithin the CD4-positive cells (Fig. 4B).
The coincidence of long-lasting disease (5 years) same T-cell clones upon relapses. This again points to
with low CD28 expression (	80%) and of short-term an antigen-specific T-cell activation.
disease and normal CD28 expression was statistically The second marker of replicative senescence, the loss
significant (chi-square 5.86; P 	 0.025). of CD28, followed the same pattern as the shortening
of the telomeres. Massive loss was only seen in patients
DISCUSSION with long-lasting disease, whereas newly diseased pa-
tients or patients with single episodes expressed normalReplicative senescence describes the fact that all so-
matic cells enter a state of growth arrest after a finite levels of CD28. There was an association between re-
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Fig. 3. Surface expression of CD28 on T cells of healthy donors. (A )
By cytofluorometry CD28 was detected on more than 90% of peripheral
T cells of the donor fri (left panel), but only on 32% of clonally expanded
Fig. 4. Surface expression of CD28 on T cells of patients with Wegen-T cells (fri-t) after 4 months in culture and after approximately 30 cell
er’s granulomatosis, patients with renal disease of nonimmune origin,doublings (right panel). The upper panels show the isotype controls for
and of healthy donors. (A ) By double-labeling cytofluorometry, thethe PE-labeled antibody. (B) CD28 expression on T cells of healthy
percentage of CD3-positive cells expressing also CD28 was determineddonors of different age: Each group contains five to ten donors; in donors
in patients with Wegener’s granulomatosis. Shown here is CD28 onolder than 80 years, a decline in CD28 expression was seen (P 	 0.05).
T cells of all patients (N  44), of patients with a single episode of the
disease (N  11), of patients with disease for more than 5 years (N 
22), and with disease for 5 years or less (N  11). On the right, data
derived from eight patients with renal disease of nonimmune origin
and of 30 healthy, age-matched donors are shown. The boxes containduced CD28 expression and the presence of short telo-
50% of the values, depicted is the median (horizontal bar). Differencesmeres, and, vice versa, normal expression of CD28 and
between the groups were calculated using the t test. (B ) Expression of
normal telomere length. In that, loss of CD28 in the CD28 on CD30-positive, CD4-positive, and CD8-positive T cells of
patients with long-lasting disease (N  7). In all patients, the losscourse of disease might be taken as a further indicator
of CD28 was occurred primarily within the CD8-positive subset.of replicative senescence occurring as a consequence of
repeated, continuous oligoclonal T-cell activation.
The assumption is supported by the fact that in pa-
tients with renal disease of nonimmune origin normal ation (e.g., HIV- infection [21, 22] or chronic inflamma-
CD28 expression and normal telomeres were found, tory disease [23, 30]) and is as such not specific for Wege-
while loss of CD28 and shortening of telomeres has been ner’s granulomatosis. Similar to those, disease is also the
preferential loss from CD8-positive T cells as opposeddiscribed in other diseases associated with T-cell prolifer-
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